Accession Number : ADA332967

Title :   Treatment of Premenstrual Dysphoric Disorder With Sertraline During the Luteal Phase

Descriptive Note : Final rept 1 Dec 94-30 Sep 95

Corporate Author : WALTER REED ARMY MEDICAL CENTER WASHINGTON DC

Personal Author(s) : Hurt, Peyton H.

PDF Url : ADA332967

Report Date : OCT 1995

Pagination or Media Count : 19

Abstract : The authors designed a randomized, double-blind, crossover study to assess the efficacy of Sertraline in the treatment of Premenstrual Dysphoric Disorder (PMDD) when given only during the luteal phase of the menstrual cycle. Thirty-one subjects were selected for a seven month study period.

Descriptors :   *MENSTRUATION, THERAPY, DRUGS, PLACEBOS, PHARMACOLOGY, PSYCHOANALEPTIC AGENTS.

Subject Categories : Anatomy and Physiology
      Medicine and Medical Research
      Pharmacology

Distribution Statement : APPROVED FOR PUBLIC RELEASE